BioNTech vaccine creates 10 times more antibodies than Sinovac, study finds
South China Morning Post A new Hong Kong study has found that recipients of the BioNTech Covid-19 vaccine have 10 times more antibodies than those who took Sinovac, with the latter generating levels of the virus-targeting proteins that were "similar or lower" than the naturally occurring ones seen in recovered patients. The findings by the University of Hong Kong, published in Lancet Microbe on Friday (July 16), could suggest the need for "alternative strategies" - including booster shots - to increase Sinovac recipients' antibody concentrations and protection against Covid-19, according to t...